Indian drug maker Dr. Reddy's Laboratories Ltd. (REDY.BO: Quote, Profile, Research) will pay British private equity firm 3i (III.L: Quote, Profile, Research) up to 480 million euros ($572 million) for German generic .

Click the following link http://ww4.6URL.com/0FR7 to read the complete article.